TOUYUN BIOTECH(01332)

Search documents
透云生物(01332) - 2023 - 年度财报
2024-04-29 14:35
Financial Performance - For the fiscal year ending December 31, 2023, the company reported revenue of approximately HKD 198.6 million, a decrease of about 37.1% compared to HKD 315.8 million in 2022[7] - The net loss for the fiscal year was approximately HKD 272.6 million, an increase of about 34.5% from HKD 202.7 million in 2022[7] - The decrease in revenue was primarily due to a reduction in sales orders for packaging products[7] - The QR code business generated revenue of approximately HKD 70.8 million, down about 28.8% from HKD 99.4 million in 2022, with a segment loss of approximately HKD 28 million[15] - The packaging products business recorded revenue of approximately HKD 106.9 million, a decrease of about 49.4% from HKD 211.3 million in 2022, resulting in a segment loss of approximately HKD 1.7 million[16] - The revenue from the Rhyne algae product business was approximately HKD 20,300,000, an increase from HKD 12,600,000 in 2022, primarily due to increased sales in China[20] - The segment loss for the Rhyne algae product business was approximately HKD 106,100,000, a significant increase from HKD 9,400,000 in 2022, mainly due to impairment of property, plant, and equipment[20] Cash and Debt Management - As of December 31, 2023, the group held cash reserves of approximately HKD 34,500,000, down from HKD 128,100,000 in 2022[22] - The debt-to-equity ratio increased to approximately 20.6 from 1.26 in 2022, primarily due to the group's net loss[22] - The group has no significant acquisitions or disposals of subsidiaries, associates, or joint ventures during the year[25] - The company raised a net amount of HKD 203,300,000 for expanding and developing its QR code business, with the full amount utilized for this purpose[37] - The group is actively negotiating with banks/lenders to extend loans maturing before December 31, 2024, to ensure necessary funding for future operational and financial needs[179] Employee and Operational Insights - The group employed approximately 563 full-time employees and 5 part-time employees as of December 31, 2023, compared to 570 full-time and 8 part-time employees in 2022[31] - Total employee costs, including director remuneration, amounted to approximately HKD 63,300,000 in 2023, down from HKD 76,300,000 in 2022, representing a decrease of about 17.5%[91] - The average training time for employees reached 28.86 hours, with a training coverage rate of 80% during the year[189] - The company provided career development and safety training for employees[1] Corporate Governance - The board of directors emphasizes the importance of good corporate governance for sustainable growth in all business environments[109] - The company has complied with all applicable corporate governance codes as of December 31, 2023, with one non-executive director absent from the annual general meeting due to other business commitments[110] - The audit committee held two meetings during the fiscal year ending December 31, 2023, reviewing the annual performance and ensuring compliance with applicable accounting standards[126] - The board has established three committees: audit, remuneration, and nomination, to ensure clear delineation of responsibilities and effective governance[124] - The company has adopted a shareholder communication policy, which is regularly monitored and reviewed by the board[158] Environmental and Social Responsibility - The company is committed to environmental policies aimed at reducing its impact and enhancing employee awareness of energy conservation[165] - The company has established a zero-tolerance policy towards corruption and encourages reporting of unethical behavior[170] - The company established an internal environmental operation control procedure to manage environmental factors[200] - The company registered seven software copyrights to protect intellectual property[1] - The company donated RMB 3,000 to community investment initiatives[1] - The company conducted 65 hours of volunteer service activities[1] Future Outlook and Strategic Initiatives - The company plans to enhance market exposure and sales through various marketing activities in 2023, aiming to deepen consumer recognition of its products[10] - The company aims to strengthen product and process R&D to improve production efficiency and reduce energy consumption[8] - New product launches in 2023 included low glycemic index foods such as noodles, instant noodles, cookies, and meal replacement powders[10] - The company has set a future outlook with a revenue guidance of $600 million for the next fiscal year, indicating a projected growth of 20%[56] - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by 2025[56] Risk Management - The independent auditor has expressed a disclaimer of opinion regarding the company's ability to continue as a going concern due to significant uncertainties[174] - The board believes that measures being taken will restore the company's financial condition and address uncertainties related to going concern[174] - The company maintains an internal audit function to monitor the effectiveness of risk management and internal control systems[159] - The board believes that the company has complied with the corporate governance code regarding risk management and internal control[160]
透云生物(01332) - 2023 - 年度业绩
2024-03-28 13:59
Financial Performance - For the fiscal year ending December 31, 2023, the company reported a total loss of HKD 272,569,000, compared to a loss of HKD 202,656,000 in 2022, representing a year-over-year increase in loss of approximately 34.4%[9] - The total comprehensive loss for the year was HKD 271,023,000, compared to HKD 217,395,000 in 2022, reflecting an increase of approximately 24.6%[14] - The group reported a net loss of HKD 272,585 thousand before tax in 2023, compared to a loss of HKD 199,183 thousand in 2022, representing an increase in loss of about 36.8%[50] - The group recorded a loss attributable to shareholders of HKD 268,939,000 for the year ended December 31, 2023, compared to a loss of HKD 198,065,000 in 2022[67] - The loss for the fiscal year was approximately HKD 272.6 million, an increase of about 34.5% from HKD 202.7 million in 2022, primarily due to reduced orders and impairment of property, plant, and equipment[131] Revenue and Sales - The company's revenue from sales of goods and services was HKD 198,032,000, while the cost of sales was HKD 142,036,000, resulting in a gross profit of HKD 55,996,000, down from HKD 127,628,000 in the previous year[7] - The group reported total revenue of HKD 198,032 thousand for 2023, a decrease from HKD 323,334 thousand in 2022, representing a decline of approximately 38.8%[50] - The revenue from the QR code business segment was HKD 70,800 thousand in 2023, down from HKD 99,373 thousand in 2022, reflecting a decrease of about 28.7%[50] - The packaging products business segment generated revenue of HKD 106,909 thousand in 2023, compared to HKD 211,344 thousand in 2022, indicating a decline of approximately 49.5%[50] - The revenue from the China market was HKD 298,949,000 in 2023, down from HKD 370,465,000 in 2022, representing a decline of 19.3%[53] Assets and Liabilities - The company's cash and cash equivalents decreased to HKD 34,493,000 from HKD 128,098,000 in the previous year, indicating a decline of approximately 73%[18] - The company's total liabilities decreased to HKD 380,713,000 from HKD 409,996,000, showing a reduction of about 7.1%[18] - Current liabilities exceeded current assets by HKD 218,229,000, raising significant doubts about the company's ability to continue as a going concern[22] - The net asset value attributable to equity holders decreased significantly to HKD 21,073,000 from HKD 283,509,000[24] - The company recorded a total of HKD 198,640,000 in non-current assets in 2023, a decrease from HKD 315,825,000 in 2022, indicating a decline of 37.1%[53] Operational Strategies and Measures - The company plans to actively seek additional financing sources, including loans from directors, to address liquidity issues[22] - The company aims to expand the sales market for its products in mainland China to improve liquidity and profitability[28] - The company is implementing cost control measures to enhance internal cash generation and operational cash flow[28] - The board believes that the financial situation will improve with the implementation of the above measures, addressing going concern uncertainties[28] - The company’s operational strategies include close monitoring of administrative expenses and operational costs to improve cash flow[129] Financial Investments and Fair Value - The company recorded a net fair value loss on financial assets of HKD 894,000, compared to a loss of HKD 9,899,000 in the previous year, indicating a significant improvement in this area[7] - The financial investment business recorded a fair value loss of approximately HKD 99.5 million, an improvement from HKD 140.3 million in 2022[135] - The group recognized a fair value loss of HKD 1,790,000 upon the sale of all shares in Evergrande Auto, with the total sale amounting to HKD 5,731,000[78] Share Capital and Stock Options - The company’s issued and fully paid share capital remained unchanged at HKD 112,238,000 for both 2022 and 2023[102] - A total of 83,031,000 stock options have been granted and remain unexercised, representing approximately 2.96% of the total shares issued as of the announcement date[107] - The company recognized approximately HKD 2,587,000 in share-based payments for the year ended December 31, 2023, down from HKD 6,859,000 in 2022[117] - The average value per stock option for the year ended December 31, 2023, is estimated between HKD 0.451 and HKD 0.545[117] - The total stock options outstanding as of December 31, 2023, is 47,000,000, with 11,000,000 options canceled[112] Corporate Governance - The company has adhered to the corporate governance code as per the Hong Kong Stock Exchange rules, with one non-executive director absent from the annual general meeting held on June 9, 2023[179] - The board continuously reviews and monitors the company's practices to maintain high standards of corporate governance[180] - All directors confirmed compliance with the trading standards for securities transactions throughout the year[181] Employment and Human Resources - As of December 31, 2023, the group employed approximately 563 full-time employees and 5 part-time employees in Hong Kong and China, a decrease from 570 full-time and 8 part-time employees in 2022[149]
透云生物(01332) - 2023 - 中期财报
2023-09-28 09:29
Financial Performance - The company reported a loss attributable to shareholders of HKD 84 million for the six months ended June 30, 2023, a decrease of 4.7% compared to a loss of HKD 88.1 million for the same period in 2022[5]. - Revenue for the six months ended June 30, 2023, was approximately HKD 103.4 million, a decrease of about 37.8% from HKD 166.3 million in the same period of 2022[5]. - The overall gross profit margin for the company was 34.4% for the six months ended June 30, 2023, compared to 35.1% for the same period in 2022[5]. - The company reported a net loss attributable to the owners of the company was HKD 83,951,000, compared to HKD 88,066,000 in 2022, indicating a reduction of 4.8%[59]. - The total comprehensive loss for the period was HKD 84,178,000, an improvement from HKD 93,932,000 in the same period last year, reflecting a decrease of 10.0%[60]. - The company recorded a loss before tax of HKD 85,081,000, slightly improved from a loss of HKD 86,308,000 in the previous year, representing a decrease of 1.4%[59]. - The company reported a financial cost of HKD 4,162,000, significantly lower than HKD 20,670,000 in the previous year, indicating a decrease of 80.0%[59]. - The group’s other income, gains, and losses for the six months ended June 30, 2023, showed a net loss of HKD 45,091,000, an improvement from a loss of HKD 48,613,000 in the same period of 2022[89]. Revenue Breakdown - The QR code business generated revenue of HKD 26.5 million, a decrease of 30.6% from HKD 38.2 million in the previous year, with a segment loss of HKD 15 million[6]. - The packaging products business recorded revenue of HKD 61 million, down 50.7% from HKD 123.8 million in the previous year, with a segment profit of HKD 1.3 million[7]. - Revenue from packaging products was HKD 61,033,000, down 50.7% from HKD 123,792,000 in the previous year[85]. - Revenue from QR code packaging products and solutions was HKD 26,504,000, a decline of 30.7% from HKD 38,249,000 in 2022[87]. - Revenue from the production and sale of spirulina products increased significantly to HKD 16,808,000, compared to HKD 4,022,000 in the same period last year, representing a growth of 318.5%[87]. - Revenue from the European market for packaging products was HKD 26,505,000, a decrease of 10.3% from HKD 29,549,000 in the previous year[87]. - Revenue from the packaging products business in Hong Kong and China was HKD 25,187,000, down 69.8% from HKD 83,218,000 in 2022[87]. Assets and Liabilities - As of June 30, 2023, the company's total assets less current liabilities amounted to HKD 416,622,000, down from HKD 477,701,000 at the end of 2022[64]. - The company's cash and cash equivalents decreased significantly to HKD 40,145,000 from HKD 128,098,000 at the end of 2022, a decline of 68.7%[63]. - Non-current liabilities increased to HKD 212,730,000 from HKD 194,192,000, representing a rise of 9.6%[64]. - The company's equity attributable to owners decreased to HKD 185,494,000 from HKD 263,959,000, a decline of 29.7%[64]. - The company has a current liability exceeding current assets by approximately HKD 154,878,000, raising concerns about its ability to continue as a going concern[70]. - Trade receivables decreased from HKD 51,348,000 on December 31, 2022, to HKD 41,528,000 on June 30, 2023, with a provision for impairment of HKD 10,260,000[102]. - The group’s non-collateralized loans and interest receivables dropped from HKD 64,020,000 on December 31, 2022, to HKD 35,272,000 on June 30, 2023[105]. - Trade payables decreased from HKD 46,224,000 on December 31, 2022, to HKD 26,314,000 on June 30, 2023[108]. - Other payables and accrued liabilities totaled HKD 27,503,000 as of June 30, 2023, down from HKD 35,098,000 at the end of 2022[110]. - The group’s secured bank borrowings were HKD 59,645,000 as of June 30, 2023, compared to HKD 79,258,000 on December 31, 2022[111]. - The total amount of bank and other borrowings was HKD 380,113,000 on June 30, 2023, down from HKD 347,275,000 at the end of 2022[113]. Investments - The company reported a fair value loss of HKD 47.8 million on financial assets measured at fair value through profit or loss, compared to a loss of HKD 50.8 million in the same period last year[8]. - As of June 30, 2023, the group held listed investments valued at approximately HKD 6,200,000, unlisted investments at HKD 185,300,000, and private equity fund investments at HKD 6,500,000[36]. - The total fair value of investments as of June 30, 2023, was HKD 185,293,000, reflecting a decrease of HKD 48,272,000 compared to the previous period[38]. - The investment in China Evergrande New Energy Vehicle Group Limited amounted to 5,000,000 shares, with a fair value of HKD 6,200,000 and an unrealized loss of HKD 32,297,380[38]. - The group plans to continue monitoring its investment portfolio cautiously due to external economic challenges, including bank failures and debt default risks[50]. - The group’s investment in FreeOpt Holdings Limited showed a fair value decrease of HKD 24,483,000, with a total investment cost of HKD 150,000[36]. - The group’s investment in Seekers Partners Limited resulted in an unrealized loss of HKD 498,639, with a total investment cost of HKD 53,217[36]. - The group’s investment in Triton Algae Innovations, Ltd showed a fair value increase of HKD 8, with a total investment cost of HKD 27,300[36]. Employee and Management - As of June 30, 2023, the group had approximately 569 full-time employees in Hong Kong and mainland China, down from 570 full-time employees as of December 31, 2022[19]. - The total employee benefits expense decreased to HKD 55,377,000 in the first half of 2023, compared to HKD 65,014,000 in the same period of 2022[91]. - The company’s management team and employees were acknowledged for their professionalism and contributions to the group[22]. Shareholder and Dividends - The board did not recommend any interim dividend for the six months ended June 30, 2023, consistent with the previous year[20]. - The company reported that Mr. Wang Liang holds 622,500,000 shares, representing approximately 22.18% of the company's issued shares as of June 30, 2023[24]. - The company has commitments from directors and shareholders not to demand repayment of HKD 105,448,000 until there is sufficient cash available[71]. Stock Options and Share-Based Payments - The company has a total of 138,352,250 stock options granted under the 2012 plan, of which 78,135,577 are immediately exercisable, representing approximately 2.78% of the total issued shares as of June 30, 2023[120]. - The company recognized an expense of HKD 4,561,000 for share-based payments for the six months ended June 30, 2023, compared to HKD 8,855,000 for the same period in 2022[131]. - The stock options granted on February 21, 2019, have an exercise price of 0.48 HKD and a total of 30,000,000 options are available for other participants[124]. - The stock options granted on October 8, 2020, have an exercise price of 0.40 HKD, with a total of 36,000,000 options available for exercise[126]. - The company aims to reward and incentivize qualified participants contributing to its successful operations through the stock option plans[117]. Financial Instruments and Fair Value - The fair value of financial assets and liabilities measured at cost or amortized cost does not differ significantly from their fair value as of June 30, 2023[134]. - The total fair value of financial assets measured at fair value through profit or loss decreased from HKD 186,086,000 on December 31, 2022, to HKD 155,293,000 on June 30, 2023, reflecting a loss of HKD 30,793,000[149]. - The company experienced a net loss of HKD 140,372,000 in fair value adjustments for non-listed equity instruments during the reporting period[149]. - The fair value measurement for financial instruments did not involve any transfers between Level 1 and Level 2 inputs during the first half of 2023[143]. - The fair value of non-listed equity investments was primarily determined by the company's directors as of June 30, 2023[149].
透云生物(01332) - 2023 - 中期业绩
2023-08-25 14:02
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容 概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不對 因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 Touyun Biotech Group Limited 透 雲 生 物 科 技 集 團 有 限 公 司 (於百慕達註冊成立的有限公司) (股份代號:1332) 截 至2023年6月30日 止 六 個 月 的 中 期 業 績 透雲生物科技集團有限公司(「本公司」)董事會(「董事會」)宣佈本公司及其 附屬公司(統稱「本集團」)截至2023年6月30日止六個月的未經審核綜合業績, 連同2022年同期的比較數字如下: 簡明綜合損益及其他全面收益表 截至6月30日止六個月 2023年 2022年 附註 千港元 千港元 (未經審核) (未經審核) 財務投資收入 按公平值計入損益的持作買賣金融 資產公平值虧損,淨額 (1,274) (1,600) 放貸業務的利息收入 296 1,827 銷售所提供貨品及服務的收入 4 104,345 166,063 銷售成本 (68,437) (107,725) ...
透云生物(01332) - 2022 - 年度财报
2023-04-27 08:43
Financial Performance - For the fiscal year ended December 31, 2022, the company recorded revenue of approximately HKD 315.8 million, an increase of about 11.4% compared to HKD 283.5 million in 2021[6]. - The company reported a loss of approximately HKD 202.7 million for the fiscal year ended December 31, 2022, which is an increase of about 63.6% from a loss of HKD 123.9 million in 2021[6]. - The packaging products business generated revenue of approximately HKD 211.3 million, representing a 22.5% increase from HKD 172.5 million in 2021[15]. - The QR code business revenue decreased to approximately HKD 99.4 million, down about 15.5% from HKD 117.6 million in 2021, with a segment loss of approximately HKD 9 million[14]. - The increase in losses is attributed to reduced interest income from guaranteed financing, increased financial costs, administrative expenses, and sales and distribution costs related to the spirulina business[13]. - The group recorded a fair value loss of approximately HKD 9,900,000 for trading financial assets, compared to a loss of HKD 25,100,000 in the previous year[18]. - The revenue from the Rhyne algae product business was approximately HKD 12,600,000, a significant increase from HKD 1,300,000 in 2021, driven by increased sales in China[19]. - The segment loss for the Rhyne algae product business increased by 203.2% to approximately HKD 9,400,000, compared to HKD 3,100,000 in 2021[19]. - The group held cash reserves of approximately HKD 128,100,000 as of December 31, 2022, up from HKD 60,200,000 in 2021[23]. - The group's debt-to-equity ratio increased to approximately 1.26 from 0.67 in 2021, primarily due to increased loans for the construction of the Shanxi manufacturing facility[23]. Business Strategy and Market Focus - The company aims to enhance market exposure and sales of its products, particularly focusing on the promotion of spirulina and its derivatives in 2023[7]. - The company has received approval from the National Health Commission of China for spirulina as a new food ingredient, allowing unlimited consumption, marking its entry into the Chinese market[8]. - The optimized annual production capacity for spirulina is expected to reach 4,000 tons following the establishment of production facilities in Shanxi Province, China[8]. - The company plans to continue expanding its QR code and packaging product customer base while investing in technology improvements to enhance competitiveness[8]. - The production facility in Shanxi has an optimized annual production capacity of 4,000 tons, with plans for a second phase to increase capacity to 6,000 tons depending on market conditions[19][20]. Corporate Governance - The company’s board includes experienced professionals with backgrounds in finance, investment, and technology[57][58][61][62]. - The company has confirmed the independence of its independent non-executive directors as per the requirements of the listing rules[90]. - The board consists of two executive directors, four non-executive directors, and four independent non-executive directors, collectively responsible for the overall strategy and policy of the company[116]. - The company has adopted the standard code of conduct for securities trading by directors, ensuring compliance throughout the year[115]. - The board has established three committees: Audit Committee, Remuneration Committee, and Nomination Committee to oversee various aspects of governance[116]. - The audit committee's main responsibilities include reviewing the financial information and overseeing the financial reporting system and internal control procedures[127]. - The company’s governance practices include regular reviews of the effectiveness of its internal control and risk management systems[129]. - The board believes that the group has implemented appropriate risk management and internal control systems, including financial, operational, and compliance monitoring[160]. Employee and Social Responsibility - The total employee cost, including director remuneration, was approximately HKD 76.3 million in 2022, up from HKD 66.3 million in 2021, representing a year-on-year increase of about 15%[94]. - As of December 31, 2022, the company had approximately 578 employees, an increase from 517 employees in 2021, indicating a growth of about 11.8%[92]. - Employee health and safety are prioritized, with a comprehensive occupational health management system and multi-level training opportunities to foster career development[179]. - The company emphasizes corporate social responsibility, encouraging employee participation in volunteer activities and maintaining compliance with legal and ethical standards[182]. - The company conducted 64 hours of volunteer service activities as part of its community engagement[1]. Environmental Impact and Sustainability - The company has established an environmental policy aimed at reducing environmental impact and promoting employee awareness of energy conservation and waste recycling[164]. - The company implemented a series of energy efficiency measures to minimize carbon footprint during operations[190]. - The company established an environmental management system based on ISO 9001:2015 and ISO 14001:2015 standards[190]. - The company aims to continuously reduce packaging material consumption based on 2020 as the baseline year[194]. - The company strictly adheres to national water pollution prevention policies and has established wastewater management procedures[200]. Financial Services and Investments - The company is engaged in various financial services including securities trading, asset management, and lending[52][53][54][56]. - The management adopts a prudent approach to oversee and review the investment portfolio and opportunities in light of ongoing inflation and rising interest rates[56]. - As of December 31, 2022, the company held investments totaling approximately HKD 178,600,000 in non-listed investments, with significant losses reported for some holdings[45]. - The company issued USD 40,000,000 convertible bonds in November 2017, with a net amount of USD 39,600,000 (approximately HKD 309,400,000) allocated for QR code business expansion and general operational funds[42]. Customer and Supplier Relations - The company's total revenue from the top five customers accounted for approximately 51.0% of total revenue, with the largest customer contributing about 21.8%[84]. - The company's total procurement from the top five suppliers represented approximately 43.0% of total procurement, with the largest supplier accounting for about 18.2%[84]. - The average customer satisfaction rate achieved 90%[1]. Shareholder Communication and Participation - The company encourages shareholder participation in annual general meetings, where board members will address shareholder inquiries[158]. - The company has established mechanisms for shareholders to request special meetings and submit resolutions[148]. - The company has adopted a shareholder communication policy, which is regularly monitored and reviewed by the board to ensure effectiveness[158].
透云生物(01332) - 2022 - 年度业绩
2023-03-27 14:29
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容 概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不對 因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 Touyun Biotech Group Limited 透 雲 生 物 科 技 集 團 有 限 公 司 (於百慕達註冊成立的有限公司) (股份代號:1332) 截 至2022年12月31日 止 年 度 的 全 年 業 績 公 告 透雲生物科技集團有限公司(前稱中國透雲科技集團有限公司)(「本公司」) 董事會(「董事會」)公佈本公司及其附屬公司(統稱「本集團」)截至2022年12 月31日 止 年 度 的 綜 合 全 年 業 績,連 同 截 至2021年12月31日 止 年 度 的 比 較 數字如下: ...
透云生物(01332) - 2022 - 中期财报
2022-09-21 09:40
Financial Performance - For the six months ended June 30, 2022, the company reported a loss attributable to shareholders of HKD 88.1 million, an increase of 43.5% compared to a loss of HKD 61.4 million for the same period in 2021[9]. - Revenue for the same period was approximately HKD 166.3 million, representing a 21.6% increase from HKD 136.8 million in the prior year[9]. - The overall gross margin decreased to 35.1% from 39.1% in the previous year[9]. - The company reported a net loss of approximately HKD 88,258,000 for the six months ended June 30, 2022, compared to a loss of HKD 72,074,000 in the same period of 2021, representing an increase in loss of about 22.5%[117]. - The gross profit for the period was HKD 58,338,000, compared to HKD 54,417,000 in the previous year, indicating a gross margin improvement[117]. - The company reported a pre-tax loss of HKD 65,014,000 for the six months ended June 30, 2022, compared to HKD 58,294,000 in the same period of 2021[179]. - The total employee benefits expenses, including directors' remuneration, amounted to HKD 65,014,000 in 2022, compared to HKD 58,294,000 in 2021, reflecting an increase of approximately 11.5%[179]. Segment Performance - The QR code business generated revenue of HKD 38.2 million, a decrease of 33.2% compared to HKD 57.2 million in the same period last year, resulting in a segment loss of HKD 4.6 million[10]. - The packaging products business recorded revenue of HKD 123.8 million, a significant increase of 51.2% from HKD 81.9 million in the prior year, with a segment profit of HKD 13.1 million[14]. - Revenue from the production and sale of packaging products reached HKD 123,792,000 in 2022, up from HKD 81,885,000 in 2021, indicating a significant increase of about 51%[166]. - The revenue from QR code packaging products and solutions was HKD 38,249,000, down from HKD 57,221,000 in 2021, reflecting a decrease of approximately 33.1%[171]. Financial Position - The company held cash reserves of approximately HKD 35 million as of June 30, 2022, down from HKD 60.2 million at the end of 2021[17]. - The debt-to-equity ratio increased to approximately 0.99 from 0.67 at the end of 2021[17]. - The company's current liabilities exceeded current assets by approximately HKD 283,458,000 as of June 30, 2022[107]. - The company's net asset value decreased to HKD 401,968 thousand as of June 30, 2022, down from HKD 487,045 thousand as of December 31, 2021, a decline of about 17.4%[123]. - The total equity attributable to the owners of the company was HKD 385,032 thousand as of June 30, 2022, down from HKD 469,917 thousand as of December 31, 2021, a decrease of approximately 17.9%[123]. - The company’s total current liabilities increased to HKD 294,109 thousand as of June 30, 2022, compared to HKD 268,217 thousand as of December 31, 2021, an increase of approximately 9.7%[122]. Cash Flow and Financing - The company's net cash flow from operating activities for the six months ended June 30, 2022, was a negative HKD 62,056 thousand, compared to a negative HKD 151,523 thousand for the same period in 2021, indicating an improvement[131]. - The company’s cash flow from investing activities showed a net outflow of HKD 114,420 thousand for the six months ended June 30, 2022[131]. - The company raised net new borrowings of HKD 44,646 thousand during the financing activities for the six months ended June 30, 2022[131]. - The company is actively negotiating loan restructuring with existing lenders to extend repayment schedules and alleviate financial constraints[111]. - Financial institutions have expressed willingness to provide new loans to the company for operational funding[137]. Shareholder Information - As of June 30, 2022, the company has a total of 624,000,000 shares held by Mr. Wang Liang, representing approximately 27.58% of the total issued shares[38]. - The company’s shareholding structure includes significant holdings by major shareholders, with Mr. Wang Liang holding 22.24% and Ms. Qiao Yan Feng holding 5.35%[45]. - The company did not recommend any interim dividend for the six months ended June 30, 2022[31]. - The weighted average number of ordinary shares used to calculate basic and diluted loss per share was 2,805,952,000 for the six months ended June 30, 2022, compared to 2,785,759,000 for the same period in 2021[187]. Investments and Acquisitions - A total of HKD 142,700,000 is allocated for expanding and developing its QR code business, with RMB 55,000,000 (approximately HKD 63,000,000) used for acquiring a subsidiary in China[57]. - The company has completed the acquisition of Tongyun Internet Technology (Beijing) Co., Ltd. in March 2017, with HKD 63,000,000 fully utilized for this acquisition[57]. - The company plans to maintain a flexible investment portfolio to withstand potential market volatility in the second half of 2022[99]. Corporate Governance - The company has committed to adhering to corporate governance codes throughout the six months ending June 30, 2022, with one non-executive director absent from the annual general meeting[100]. - There were no significant investments, acquisitions, or disposals during the reporting period[29].
透云生物(01332) - 2021 - 年度财报
2022-04-28 12:14
Financial Performance - For the fiscal year ended December 31, 2021, the company recorded revenue of approximately HKD 283.5 million, an increase of about 37.1% compared to HKD 206.8 million in 2020[9]. - The company's loss for the fiscal year was approximately HKD 123 million, a decrease of about 28.5% from a loss of HKD 172 million in 2020[17]. - The QR code business generated revenue of approximately HKD 117.6 million, representing a 41.2% increase from HKD 83.3 million in 2020, with a segment profit of approximately HKD 24.2 million compared to a loss of HKD 6.5 million in the previous year[18]. - The packaging products business recorded revenue of approximately HKD 172.5 million, an increase of about 27.4% from HKD 135.4 million in 2020, with a segment profit of approximately HKD 7.5 million, up 44.2% from HKD 5.2 million[19]. - The revenue from the spirulina product business increased significantly to approximately HKD 1,300,000, up from HKD 41,000 in the previous year, marking a substantial growth[24]. Business Strategy and Operations - The company plans to optimize production capacity for its spirulina products, aiming for an annual capacity of 4,000 tons by the second half of 2022[10]. - The company will continue to expand its customer base in the QR code and packaging product businesses, investing resources to enhance QR code technology[10]. - The company believes that natural health products, such as spirulina and microalgae products, have growth potential, especially in the context of increasing health awareness due to the COVID-19 pandemic[10]. - The company has constructed production facilities for spirulina and related products in Shanxi Province, China, with production capacity gradually increasing[10]. - The company aims to further expand its market presence in other countries supported by a stable supply of spirulina[10]. Financial Investments - The financial investment business recorded a fair value loss of HKD 25,100,000 for the year, compared to a loss of HKD 14,200,000 in the previous year[22]. - The company sold shares of Genius Spring Limited for HKD 40,000,000, resulting in a loss of approximately HKD 8,300,000[37]. - The sale of Hope Capital Limited shares generated HKD 160,000,000, with a loss of about HKD 14,300,000 recognized[37]. - The group employed approximately 509 full-time employees and 8 part-time employees as of December 31, 2021, compared to 506 full-time employees in 2020[47]. - The company invested approximately HKD 16,156,000 in financial products as of December 31, 2021[62]. Corporate Governance - The company has adopted a stock option plan as a long-term incentive for eligible employees and directors[123]. - The board of directors has confirmed the independence of independent non-executive directors as per the relevant regulations[116]. - The company has established an executive committee responsible for overseeing management and daily operations[172]. - The board has not established a corporate governance committee, with its functions being collectively undertaken by the board[172]. - The company provides regular updates to directors regarding business changes and developments to assist informed decision-making[149]. Shareholder Information - Shareholders can request a special general meeting if they hold at least 10% of the voting rights of the company[191]. - If the board does not convene a special general meeting within 21 days of the request, the requesting shareholders can call the meeting themselves within 3 months[194]. - Shareholders can submit written requests to propose resolutions for the upcoming annual general meeting, including notices and statements not exceeding 1,000 words[196]. - Valid requests can be made by shareholders holding at least 5% of the total voting rights or by at least 100 shareholders[197]. - The company is required to provide notice to shareholders regarding any proposed resolutions for the upcoming annual general meeting[196]. Employee and Director Compensation - The total remuneration paid to the independent auditor was approximately HKD 1,900,000, with HKD 1,500,000 for audit services and HKD 400,000 for non-audit services[187]. - The salary range for senior management shows that 9 individuals earned less than HKD 1,000,000, while 2 individuals earned between HKD 1,000,001 and HKD 2,000,000[178]. - The compensation committee consists of two executive directors and three independent non-executive directors, with a focus on recommending compensation policies for directors and senior management[177]. - In the fiscal year ending December 31, 2021, the compensation committee held one meeting, with all members present[178]. Audit and Compliance - The financial statements have been audited by Deloitte Touche Tohmatsu Certified Public Accountants[139]. - The audit committee held two meetings during the fiscal year ending December 31, 2021, with attendance as follows: Xia Qicai (2/2), Zhang Rongping (1/2), and Du Chengquan (2/2)[174]. - The audit committee reviewed the group's annual performance for the fiscal year ending December 31, 2021, ensuring compliance with applicable accounting standards[174]. - The company has complied with the corporate governance code as per the listing rules throughout the year[143].
透云生物(01332) - 2021 - 中期财报
2021-09-16 22:36
Financial Performance - The company reported a loss attributable to shareholders of HKD 61.4 million for the six months ended June 30, 2021, a decrease of 25.3% compared to a loss of HKD 82.2 million for the same period in 2020[9]. - Revenue for the six months ended June 30, 2021, was approximately HKD 136.8 million, representing an increase of about 49.7% from HKD 91.4 million in the same period of 2020[9]. - The overall gross margin for the group was 39.1%, slightly up from 39% for the six months ended June 30, 2020[9]. - The company reported a loss of HKD 72,074,000 for the six months ended June 30, 2021, compared to a loss of HKD 82,712,000 for the same period in 2020, representing a 12.5% improvement in performance[109]. - The overall comprehensive loss for the period totaled HKD 73,242,000, down from HKD 86,782,000 in the same period last year, showing a positive trend in overall financial performance[111]. - The company's basic and diluted loss per share improved to HKD 2.20 from HKD 3.19 in the previous year, reflecting a reduction in losses per share[109]. Revenue Breakdown - The QR code business generated revenue of HKD 57.2 million, a 67.7% increase from HKD 34.1 million in the previous year, with a segment profit of HKD 7.3 million[11]. - The packaging products business recorded revenue of HKD 81.9 million, up 25.6% from HKD 65.2 million in the same period last year, achieving a segment profit of HKD 2.4 million[12]. - Total revenue from sales of goods and services reached HKD 139,197,000, with a cost of sales amounting to HKD 84,780,000, resulting in a gross profit of HKD 54,417,000[109]. - Revenue from the production and sale of packaging products and QR code solutions was HKD 81,885,000, up from HKD 65,214,000 in the previous year, representing a growth of 25.6%[153]. - The revenue recognized at a point in time was HKD 139,188,000 for the six months ended June 30, 2021, compared to HKD 98,934,000 for the same period in 2020, reflecting a significant increase[156]. Financial Position - As of June 30, 2021, the group held cash reserves of HKD 76.5 million, down from HKD 142.4 million as of December 31, 2020[17]. - The debt-to-equity ratio as of June 30, 2021, was 0.48, compared to 0.28 as of December 31, 2020[17]. - The company's total assets as of June 30, 2021, amounted to HKD 1,136,991,000, an increase from HKD 971,940,000 in 2020, indicating growth in asset base[114]. - Cash and cash equivalents decreased to HKD 76,540,000 from HKD 142,440,000 in the previous year, highlighting liquidity challenges[114]. - The net value of current assets was HKD 28,486,000, compared to a net value of HKD 56,030,000 in the previous year, indicating a decline in current asset liquidity[114]. - The total equity attributable to the owners of the company rose to HKD 619,304 thousand as of June 30, 2021, compared to HKD 556,369 thousand at the end of 2020, marking an increase of approximately 11.3%[119]. Investments and Capital Expenditures - The company raised a net amount of HKD 406,100,000 from a share placement in November 2016, with HKD 263,400,000 used for the redemption of promissory notes[46]. - A total of HKD 142,700,000 was allocated for the expansion and development of its QR code business, including RMB 55,000,000 (approximately HKD 63,000,000) for the acquisition of a subsidiary in China[49]. - The company utilized HKD 58,700,000 for research and development, including hiring technical personnel[52]. - The company reported a total investment cost of HKD 520,742,000 as of June 30, 2021[80]. - The company has allocated HKD 30,800,000 for general office operating funds, which has been fully utilized[76]. Employee and Operational Updates - As of June 30, 2021, the company had approximately 506 employees in Hong Kong and mainland China[25]. - The company launched its new product, Rhizoclonium noodles, through the HKTV mall online sales channel during the reporting period[124]. - The company opened a retail store in "百味市集" located in Causeway Bay, Hong Kong, in August 2021, further expanding its market presence[124]. Debt and Liabilities - The company incurred a fair value loss of HKD 13.5 million on financial assets held for trading, compared to a loss of HKD 8.3 million in the same period last year[13]. - The company reported a net cash outflow from operating activities of HKD (151,523) thousand for the six months ended June 30, 2021, compared to a net inflow of HKD 35,690 thousand for the same period in 2020[122]. - The group’s total liabilities decreased from HKD 1,378,446 thousand as of December 31, 2020, to HKD 1,687,868 thousand as of June 30, 2021[119]. - The group’s uncollateralized borrowings amounted to HKD 149,539,000 as of June 30, 2021, significantly higher than HKD 58,990,000 as of December 31, 2020[195]. Shareholder Information - The board of directors did not recommend any interim dividend for the six months ended June 30, 2021, consistent with the previous year[26]. - The company reported a total of 624,000,000 shares held by Mr. Wang Liang, representing approximately 22.26% of the issued shares[37]. - The average weighted number of ordinary shares for calculating basic and diluted loss per share was 2,785,759,000 shares, compared to 2,574,810,000 shares in the previous year[173]. Financial Instruments and Risk Management - The company did not use any foreign exchange hedging products during the period to manage currency risks, closely monitoring exchange rate fluctuations[24]. - The company incurred a fair value loss of HKD 25,560,000 on convertible bonds embedded derivatives during the first half of 2021[161]. - The convertible bonds' maturity date has been extended from November 10, 2019, to November 10, 2021, as per the revised agreement[200]. - The interest on the convertible bonds is set at an annual rate of 12% from November 10, 2019, to the revised maturity date[200].
透云生物(01332) - 2020 - 年度财报
2021-04-13 22:34
Financial Performance - The company recorded revenue of approximately HKD 206.8 million for the year ended December 31, 2020, a decrease of about 39.7% compared to HKD 342.7 million in 2019[8]. - The loss for the year ended December 31, 2020, was HKD 172 million, a reduction of 13.6% from a loss of HKD 199.1 million in 2019[9]. - Revenue from the QR code business was HKD 83.3 million, an increase from HKD 69.7 million in 2019, with a significant reduction in segment loss by 96.7% to HKD 6.5 million[15]. - The packaging products business generated revenue of HKD 135.4 million, down 48.0% from HKD 260.3 million in 2019, with segment profit decreasing by 74.6% to HKD 5.2 million[16]. Investments and Acquisitions - The acquisition of Hope Capital Limited was completed, with the company holding 83.9% of its equity post-acquisition, enhancing its capabilities in securities brokerage and asset management[18]. - Galaxy Vantage Limited acquired 100% of Hope Capital Limited for the issuance of 13,513 new shares, resulting in a 83.9% ownership stake in Hope Capital[105]. - The company held listed and unlisted investments valued at approximately HKD 112,000,000 and HKD 320,700,000, respectively[71]. - The investment in 渝太地產集團有限公司 resulted in a loss of HKD 3,000,000 for the year ended December 31, 2020, with a total investment cost of HKD 30,000,000[75]. - The investment in 威華達控股有限公司 showed a loss of HKD 27,163,000, with a fair value of HKD 46,217,000 as of December 31, 2020[75]. Business Strategy and Development - The company is diversifying its business into health food products, including the construction of a production facility for microalgae in Shanxi Province, with an expected annual production capacity of 10,000 tons[10]. - The company aims to start production of microalgae and related products in 2021, capitalizing on the growing health food market[10]. - The overall strategy includes expanding into complementary businesses to enhance the financial investment segment[18]. - The company continues to develop its QR code solutions and packaging products, seeking new business opportunities to meet increasing customer demand[10]. Financial Position and Capital Management - As of December 31, 2020, the company held outstanding convertible bonds amounting to HKD 112,200,000, a decrease from HKD 225,200,000 in 2019[21]. - The company had cash reserves of HKD 142,400,000 as of December 31, 2020, compared to HKD 40,500,000 in 2019[21]. - The asset-to-equity ratio was 0.28 as of December 31, 2020, down from 0.36 in 2019[21]. - The company raised a total of HKD 50,000,000 through share subscription agreements at HKD 0.37 per share, which will be used for general working capital[22]. Corporate Governance - The financial statements have been audited by Deloitte Touche Tohmatsu Certified Public Accountants[142]. - The board consists of three executive directors, four non-executive directors, and four independent non-executive directors[147]. - The company has adopted a share option scheme since May 18, 2012[133]. - The audit committee conducted two meetings during the fiscal year ending December 31, 2020, with full attendance from its members[160]. - The company has maintained sufficient public float as per listing rules as of December 31, 2020[141]. Risk Management - The company has maintained a robust internal control system to manage risks and ensure compliance with laws and regulations[192]. - The internal audit function focuses on identifying, monitoring, and reporting major risks faced by the group, including operational, legal compliance, and financial reporting risks[192]. - The company has faced risks from unstable consumer markets and rising labor costs in mainland China, which may impact its operations[193]. - The company plans to adopt a prudent business strategy and balanced risk management in response to the uncertainties caused by COVID-19[86]. Shareholder Information - The company does not recommend any final dividend for the year ended December 31, 2020, consistent with the previous year[109]. - The total interest held by Mr. Wang and Ms. Qiao amounts to 711,500,000 shares, representing approximately 25.7% of the issued shares[131]. - The company has a policy for shareholders to request special general meetings, requiring a written request from shareholders holding at least 10% of the voting rights[177]. Environmental and Social Responsibility - The company has implemented an environmental policy aimed at reducing its environmental impact and promoting energy-saving practices[196]. - The company emphasizes the importance of relationships with employees, customers, and business partners for sustainable development[197].